10.87
전일 마감가:
$11.24
열려 있는:
$11.25
하루 거래량:
571.91K
Relative Volume:
0.58
시가총액:
$945.82M
수익:
-
순이익/손실:
$-106.81M
주가수익비율:
-3.2823
EPS:
-3.3117
순현금흐름:
$-8.40M
1주 성능:
+2.74%
1개월 성능:
+25.23%
6개월 성능:
+9.25%
1년 성능:
-32.19%
이뮤놈 Stock (IMNM) Company Profile
명칭
Immunome Inc
전화
610-321-3700
주소
18702 N. CREEK PARKWAY, BOTHELL
IMNM을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IMNM
Immunome Inc
|
10.87 | 978.02M | 0 | -106.81M | -8.40M | -3.3117 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
이뮤놈 Stock (IMNM) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-02 | 개시 | Lake Street | Buy |
2024-11-08 | 개시 | Stephens | Overweight |
2024-05-31 | 개시 | Piper Sandler | Overweight |
2024-04-30 | 개시 | JP Morgan | Overweight |
2024-04-15 | 개시 | Guggenheim | Buy |
2024-01-29 | 개시 | Leerink Partners | Outperform |
2023-12-19 | 개시 | Wedbush | Outperform |
2021-10-29 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
이뮤놈 주식(IMNM)의 최신 뉴스
What analysts say about Immunome Inc. stockExplosive capital appreciation - PrintWeekIndia
Immunome Inc. Stock Analysis and ForecastFastest return on investment - PrintWeekIndia
Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Arizona State Retirement System - Defense World
Is Immunome Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Teacher Retirement System of Texas Boosts Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
What drives Immunome Inc. stock priceTriple-digit wealth increases - Autocar Professional
Will Immunome Inc. stock benefit from AI tech trendsAnalyst Grade Signals - Newser
What makes Immunome Inc. stock attractive to long term investorsPrecision Entry Strategy - Newser
Immunome Inc (IMNM) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Bullish Immunome Insiders Loaded Up On US$3.84m Of Stock - simplywall.st
Unraveling Immunome's 15% Surge: Technical Bullishness or Hidden Catalysts? - AInvest
Immunome's 13% Spike: Unraveling the Mysterious Rally - AInvest
(IMNM) Trading Report - news.stocktradersdaily.com
Unraveling the Immunome Stock Surge: A Technical and Market Behavior Deep Dive - AInvest
How Immunome Inc. stock performs during market volatilityBreakout Momentum Alerts - Newser
What makes Immunome Inc. stock price move sharply2x 3x 5x Pick Alert - Newser
Why Immunome Inc. stock attracts strong analyst attentionFree Investment Community - Newser
Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Wealth Enhancement Advisory Services LLC Boosts Stock Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World
Immunome (IMNM) Soars 6.0%: Is Further Upside Left in the Stock? - MSN
Immunome's Inducement Grants: A Balancing Act Between Talent Acquisition and Equity Dilution - AInvest
Immunome (IMNM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Trend Tracker for (IMNM) - news.stocktradersdaily.com
Immunome, Inc. (NASDAQ:IMNM) Stake Raised by Wealth Enhancement Advisory Services LLC - Defense World
Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High? - sharewise
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 14,328 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World
이뮤놈 (IMNM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):